发明名称 |
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS |
摘要 |
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible. |
申请公布号 |
PL1827461(T3) |
申请公布日期 |
2012.07.31 |
申请号 |
PL05823474T |
申请日期 |
2005.12.20 |
申请人 |
|
发明人 |
DE LUCA GIAMPIERO;YTHIER ARNAUD;MUNAFO ALAIN;LOPEZ-BRESNAHAN MARIA |
分类号 |
A61K31/7076;A61K38/21;A61P25/00 |
主分类号 |
A61K31/7076 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|